This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Acucela Inc., Vertex Pharmaceuticals, Inc., Rigel Pharmaceuticals, Incorporated. Active years: 2012-2026.
Company Filing History:
3 out of 98 
2 out of 1,167 
1 out of 492 
Years Active: 2012-2026
Title: Albert Cornelis Dros: Innovator in VAP-1 Modulation
Introduction
Albert Cornelis Dros is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of pharmaceutical innovations, particularly in the modulation of VAP-1 activity. With a total of 6 patents to his name, Dros continues to push the boundaries of scientific research and development.
Latest Patents
Dros's latest patents focus on inhibitors of VAP-1. These patents provide compounds and methods for the modulation of VAP-1 activity, showcasing his commitment to advancing medical science. The innovative approaches outlined in these patents have the potential to impact therapeutic strategies significantly.
Career Highlights
Throughout his career, Dros has been associated with Acucela Inc., where he has contributed to various research initiatives. His work has been instrumental in developing new therapeutic options that address critical health challenges. Dros's expertise in the field has earned him recognition among his peers.
Collaborations
Dros has collaborated with notable colleagues, including Mark W. Orme and Edison S. Zuniga. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Albert Cornelis Dros is a distinguished inventor whose work in VAP-1 modulation exemplifies the spirit of innovation. His contributions to the field are paving the way for future advancements in medical therapies.